BioMarin to Buy Amicus in $4.8 Billion Bet on Rare Disease Drugs.
Saved in:
| Title: | BioMarin to Buy Amicus in $4.8 Billion Bet on Rare Disease Drugs. |
|---|---|
| Authors: | Larkin, Catherine (AUTHOR) |
| Source: | Bloomberg.com. 12/19/2025, pN.PAG-N.PAG. 1p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Description not available. |
